Atara Biotherapeutics Will Present Recent Advancements and Key Upcoming Milestones at the 39th Annua
Search jobs 10-Jan-2021 Atara Biotherapeutics Will Present Recent Advancements and Key Upcoming Milestones at the 39th Annual J.P. Morgan Healthcare Conference Atara achieved significant progress across its three strategic priorities in 2020 Atara is well-positioned for success in anticipated tab-cel ® regulatory submissions, approval and launch Atara has had productive interactions with the FDA for ATA188 and is progressing the Phase 2 randomized clinical trial (RCT) toward an interim analysis in H1 2022 SOUTH SAN FRANCISCO, Calif.--(BUSINESS WI...
Source: pharmiweb.com